Opinion: Purple Book Patent Listings Are Only a First Step
May 8, 2021
Ted Mathias, Stacie Ropka, PhD, and Aaron Savit, PhD
The Center for Biosimilars
Axinn partners Ted Mathias and Stacie Ropka, and associate Aaron Savit authored The Center for Biosimilars article, "Opinion: Purple Book Patent Listings Are Only a First Step."
Click here to access the article.